Caladan Bio, a bioreactor startup, has raised USD 5 million in seed funding led by Twelve Below, with participation from Lerer Hippeau, Collaborative Fund, Wireframe Ventures, Ritual Capital, and Factorial Capital.
The funding will expand its team and further enhance its platform. Further, the startup plans to establish pilot partnerships for installations in 2H 2024.
Caladan Bio, founded in 2023, develops benchtop bioreactor systems to reduce the cost of experimentation for synbio companies and boost the amount of data produced from experiments. The company's initial product, the Caladan 250, is a modular 250 ml bioreactor featuring enhanced sensors and integrations for AI and ML tools.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.